CIK 0001326190 · Non-accelerated filer<br>Smaller reporting company
Altimmune, Inc.
Sign in to watch- Ticker
- ALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 202726770
- Phone
- 862-457-1450
- Business address
- 350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
- Former names
- PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-09-26 | GILL JOHN Director | Grant or award · Stock Options (option to buy) | +34,900 | 34,900 | ||
| 2024-09-26 | Jorkasky Diane Director | Grant or award · Stock Options (option to buy) | +34,900 | 34,900 | ||
| 2024-09-26 | Sohn Catherine A. Director | Grant or award · Stock Options (option to buy) | +34,900 | 34,900 | ||
| 2024-08-19 | Drutz David Director | Option exercise | +20,000 | $2.60 | $52K | 49,785 |
| 2024-08-19 | Drutz David Director | Sale | −7,827 | $6.93 | $54K | 41,958 |
| 2024-08-19 | Drutz David Director | Option exercise | +21,750 | $2.50 | $54K | 63,708 |
| 2024-08-19 | Drutz David Director | Sale | −8,184 | $6.88 | $56K | 55,524 |
| 2024-08-19 | Drutz David Director | Option exercise · Stock Options (option to buy) | −20,000 | 0 | ||
| 2024-08-19 | Drutz David Director | Option exercise · Stock Options (option to buy) | −21,750 | 4,350 | ||
| 2024-07-31 | Shutterly Andrew Acting Chief Financial Officer | Grant or award | +1,259 | $5.41 | $7K | 11,372 |
| 2024-07-31 | Roberts M Scot Chief Scientific Officer | Grant or award | +650 | $5.41 | $4K | 43,310 |
| 2024-07-31 | Jordt Raymond M Chief Business Officer | Grant or award | +917 | $5.41 | $5K | 14,660 |
| 2024-07-31 | Harris Matthew Scott Chief Medical Officer | Grant or award | +1,486 | $5.41 | $8K | 55,119 |
| 2024-02-02 | Roberts M Scot Chief Scientific Officer | Option exercise | +7,775 | 44,990 | ||
| 2024-02-02 | Roberts M Scot Chief Scientific Officer | Shares withheld for taxes | −2,330 | $9.32 | $22K | 42,660 |
| 2024-02-02 | Roberts M Scot Chief Scientific Officer | Option exercise · Restricted Stock Units | −7,775 | 15,550 | ||
| 2024-02-02 | Harris Matthew Scott Chief Medical Officer | Option exercise | +7,775 | 55,965 | ||
| 2024-02-02 | Harris Matthew Scott Chief Medical Officer | Shares withheld for taxes | −2,332 | $9.32 | $22K | 53,633 |
| 2024-02-02 | Harris Matthew Scott Chief Medical Officer | Option exercise · Restricted Stock Units | −7,775 | 15,550 | ||
| 2024-02-02 | Garg Vipin K President and CEO | Option exercise | +18,950 | 300,404 |
Page 9 of 21 · 403 trades